Weight gain is unique to each person
11 Conclusion Glucagon-like peptide-1 receptor agonists are pivotal in managing T2DM and obesity, enhancing glycaemic control by boosting insulin secretion, reducing glucagon levels, delaying gastric emptying, and promoting satiety
Dulaglutide (Trulicity): A once-weekly GLP-1 agonist for type 2 diabetes
Gastrointestinal Side Effects GLP-1 receptor agonists commonly cause GI side effects nausea, bloating, reflux/heartburn, constipation, and sometimes vomiting
Services include: Treatment for illnesses like colds or flu Management of chronic conditions such as asthma or diabetes Primary care check-ups, womens and men's health, and STD testing and treatment Vaccines Click, call or come ineasy online booking helps students take the first step toward taking charge of their health